You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
《公司業績》百濟神州(06160.HK)據美會計準則首三季虧損收窄至8.28億美元
百濟神州(06160.HK)公佈據美國公認會計準則編制、截至今年9月底止首三季業績,營業額9.62億美元(下同),按年升360.9%。虧損收窄至8.28億元,上年同期蝕11.24億元;每股虧損0.69元。 至於第三季營業額2.06億元,按年增長126.7%。虧損收窄至4.14億元,上年同期蝕4.25億元;每股虧損0.34元。 公司另外公佈,將在第63屆美國血液學會(ASH)年會及其展會上,公佈血液腫瘤研究項目的臨牀結果和真實世界數據,其中包括兩份關於臨牀3期SEQUOIA試驗的口頭報告,該試驗對比百悅澤(澤布替尼)與苯達莫司汀聯合利妥昔單抗(B+R),用於治療初治(TN)慢性淋巴細胞白血病(CLL)或小淋巴細胞淋巴瘤(SLL)患者的數據。ASH會議將於12月11至14日在美國佐治亞州亞特蘭大市以線上線下結合的形式舉行。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.
uSMART
Wealth Growth Made Easy
Open Account